Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
Recombinant
- (286)
- (11)
- (65,895)
- (1)
For Use With (Application)
- (2)
- (970)
- (1)
- (23,542)
- (5)
- (1)
- (1)
- (67)
- (218)
- (4,423)
- (23)
- (1)
- (4)
- (2)
- (13)
- (21,453)
- (3)
- (4)
- (3)
- (1)
- (2)
- (4)
- (14)
- (71)
- (2)
- (2)
- (2)
- (1)
- (3)
- (2)
- (1)
- (157)
- (3)
- (4)
- (1)
- (1)
- (1)
- (3)
- (253)
- (22,601)
- (1)
- (1)
- (2)
- (1)
- (13)
- (26,805)
- (255)
- (32)
- (3)
- (708)
- (14)
- (2)
- (1)
- (8)
- (1)
- (5)
- (1)
- (105)
- (1)
- (3,765)
- (1,407)
- (3)
- (4)
- (5)
- (1)
- (1)
- (1)
- (1)
- (14)
- (138)
- (48)
- (6)
- (17)
- (2)
- (1)
- (10)
- (4)
- (81)
- (12)
- (2)
- (3)
- (80)
- (4)
- (113)
- (96)
- (19)
- (1)
- (1)
- (4)
- (1)
- (1,523)
- (2)
- (1)
- (160)
- (18)
- (48)
- (3)
- (3)
- (1)
- (2)
- (9)
- (27)
- (2)
- (204)
- (1)
- (4)
- (1)
- (2)
- (114)
- (44)
- (2)
- (1)
- (1)
- (4)
- (1)
- (1)
- (3)
- (1)
- (23,710)
- (6)
- (3)
- (1)
- (1)
- (63)
- (6)
- (2)
- (7)
- (5)
- (1)
- (2)
- (1)
- (1)
- (6,758)
- (6)
- (4)
- (1)
- (3)
- (1)
- (3)
- (2)
- (13)
- (17)
- (1)
- (3)
- (3)
- (4)
- (27,101)
- (240)
- (1)
- (3)
Species
- (2)
- (1)
- (2)
- (1)
- (89)
- (559)
- (96)
- (2)
- (1)
- (1)
- (2)
- (1)
- (27)
- (1)
- (8)
- (15)
- (1)
- (72)
- (1)
- (1,303)
- (1)
- (3)
- (16)
- (1)
- (3)
- (1)
- (1)
- (1)
- (8)
- (1)
- (4)
- (1)
- (1)
- (29,094)
- (5)
- (22)
- (8)
- (4)
- (1,291)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (8)
- (14)
- (32)
- (24)
- (1)
- (2)
- (16)
- (233)
- (9)
- (2)
- (5)
- (1)
- (2)
- (2)
- (2)
- (23)
- (5)
- (3)
- (3)
- (2)
- (14)
- (23,574)
- (1)
- (48)
Form
- (15)
- (1)
- (2)
- (45,210)
- (5,673)
- (245)
- (168)
- (56)
- (3,363)
Conjugate
- (7)
- (1)
- (3)
- (18)
- (2)
- (62)
- (1)
- (4)
- (2)
- (9)
- (59)
- (1)
- (2)
- (3)
- (1)
- (391)
- (1)
- (3)
- (2)
- (1)
- (1)
- (1)
- (3)
- (2)
- (3)
- (19)
- (7)
- (2)
- (2)
- (3)
- (45)
- (1)
- (1)
- (1)
- (2)
- (5)
- (1)
- (1)
- (1)
- (2)
- (8)
- (2)
- (3)
- (43,112)
- (1)
- (11)
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Search Within Results
Keyword Search:
Clear All
166
–
180
of
118,333
results
166
R&D Systems™ Recombinant Human VEGF 165 Protein
Greener Choice
Offers one or more environmental benefits itemized in the U.S. FTC “Green Guides.”
Learn More
Greener Choice
Offers one or more environmental benefits itemized in the U.S. FTC “Green Guides.”
Learn More
Offers one or more environmental benefits itemized in the U.S. FTC “Green Guides.”
Learn More
| Accession Number | NP_001165097.1 |
|---|---|
| Purity or Quality Grade | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| Conjugate | Unconjugated |
| Gene Alias | MVCD1, VAS, vascular endothelial growth factor A, Vascular permeability factor, Vasculotropin, VEGFA, VEGF-A, VEGFMGC70609, VPF, VPFvascular endothelial growth factor |
| Molecular Weight (g/mol) | M.W. Observed: 19-21 kDa, under reducing conditions., M.W. Theoretical: 19.2 kDa (monomer) |
| Gene ID (Entrez) | 7422 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in Sodium Acetate. |
| Reconstitution | Reconstitute the 10 μg size at 100 μg/mL in sterile deionized water. Reconstitute all other sizes at 500 μg/mL in sterile deionized water. |
| For Use With (Application) | Bioactivity |
| Protein | VEGF |
167
Invitrogen™ Albumin from Bovine Serum (BSA), Alexa Fluor™ 555 conjugate
Suited for applications that require well-defined molecular weight tracers
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
168
Invitrogen™ Human IL-6 Recombinant Protein
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Accession Number | P05231 |
|---|---|
| Regulatory Status | RUO |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Gene ID (Entrez) | 3569 |
| Gene Symbol | Il6 |
| Source | E. coli |
| Recombinant | Recombinant |
| Name | Human IL-6 |
169
Invitrogen™ Human IL-4 Recombinant Protein
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Content And Storage | Includes 1 vial of lyophilized protein. Store at -20 °C. |
|---|---|
| Purity or Quality Grade | ≥95 % as determined by SDS-PAGE. ≥95 % as determined by SEC-HPLC. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-4 |
| Molecular Weight (g/mol) | 15 kDa |
| Gene Symbol | Il4 |
| Sequence | Human IL-4 isoform 1, amino acids His25-Ser153 (Accession # P05112-1) with an N-terminal Met |
| Expression System | E. coli |
| For Use With (Application) | Control,Bioactivity,Immunohistochemistry,Western Blot |
| Source | E. coli |
| Name | Human IL-4 |
| Accession Number | P05112 |
| Regulatory Status | RUO |
| Gene Alias | B cell growth factor 1; B_cell stimulatory factor 1; B-cell growth factor 1; B-cell IgG differentiation factor; B-cell stimulatory factor 1; BCGF1; BCGF-1; binetrakin; BSF1; BSF-1; cytokine; H-IL-4; IGG1 induction factor; IL2; IL4; Il-4; Il4e12; ILN; Interleukin; interleukin 4; interleukin 4 variant 2; interleukin 4 variant IL-4delta2; interleukin 4 variant IL-4delta3; interleukin 4 variant IL-4int2A; interleukin 4 variant IL-4int3A; interleukin 4 variant IL-4int3B; Interleukin4; interleukin-4; interleukin-4 precursor; lymphocyte stimulatory factor 1; MGC79402; M-IL-4; Pitrakinra |
| Biological Activity | Measured in a cell proliferation assay using TF-1 human erythroleukemic cells. The ED50 for this effect is 0.05-0.25 ng/mL |
| Gene ID (Entrez) | 3565 |
| Formulation | PBS with 5% mannitol, 5% trehalose, 0.01% Tween 80 and no preservative; pH 7.4 |
| Recombinant | Recombinant |
170
Invitrogen™ Mouse IL-1 beta Recombinant Protein
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Purity or Quality Grade | >97% by SDS-PAGE |
|---|---|
| Conjugate | Unconjugated |
| pH Range | 7.4 |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 17.5 kDa |
| Common Name | IL-1 beta |
| Gene Symbol | IL1B |
| Activity | 1. Measured by its ability to induce Interferon gamma secretion by human natural killer lymphoma NK-92 cells. The ED50 for this effect is typically 6-30 ng/mL. |
| Storage Requirements | -20°C or -80°C if preferred |
| Sequence | Mouse IL-1beta, amino acids Val118-Ser269 (Accession # P10749) with a C-terminal Met |
| Expression System | E. coli |
| For Use With (Application) | Control,Bioactivity,Immunohistochemistry,Western Blot |
| Name | Mouse IL-1 beta |
| Accession Number | P10749 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | catabolin; cytokine; Hematopoietin 1 (H1); IFN beta inducing factor; il 1b; IL 1β; IL-1; IL1 B; IL-1 beta; IL-1 precursor; IL1B; IL-1B; IL1B1; IL1beta; IL-1beta; IL1-BETA; IL1F2; IL1β; ILN; Interleukin; interleukin 1 beta; Interleukin 1 beta precursor; interleukin 1, beta; interleukin 1, beta 1; interleukin 1-beta; interleukin*1*beta; Interleukin1 beta; interleukin-1 beta; interleukin-1 beta precursor; interleukin-1 beta precursor (AA -113 to 153); interleukin-1 beta proprotein; interleukin-1b; interleukin-1beta; interleukin-beta; LAF; lymphocyte proliferation-potentiating factor; Osteoclast activating factor (OAF); preinterleukin 1 beta; Pro interleukin 1 beta; prointerleukin-1 beta; pro-interleukin-1-beta |
| Product Type | Protein |
| Gene ID (Entrez) | 16176 |
| Formulation | PBS with 5% mannitol, 5% trehalose, 0.01% Tween 80 and no preservative; pH 7.4 |
| Protein Tag | Untagged |
| Recombinant | Recombinant |
171
R&D Systems™ Recombinant Human IL-6 (HEK293-expressed) Protein
Measured in a cell proliferation assay using T1165.85.2.1 mouse plasmacytoma cells. ED50 for this effect is 0.1 to 0.6 ng/mL
| Buffer | Lyophilized from a 0.2 μm filtered solution in PBS. |
|---|---|
| Purity or Quality Grade | >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | M.W. (Observed): 22 kDa, reducing conditions; M.W. (theoretical): 20.8 kDa |
| Endotoxin Level | <0.10 EU per 1 μg of the protein by the LAL method. |
| Gene Symbol | IL6 |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | IL-6 |
| Source | Human embryonic kidney cell, HEK293-derived human IL-6 protein Met1-Met212 |
| Name | B cell stimulatory factor-2, B-cell differentiation factor, BSF2, BSF-2, BSF2CTL differentiation factor, CDF, HGFHSFIFNB2Hybridoma growth factor, IFNB2, IFN-beta-2, IL6, IL-6B-cell stimulatory factor 2, Interferon beta-2, interleukin 6 (interferon, beta 2), interleukin BSF-2, interleukin-6, MGI-2A |
| Accession Number | P05231 |
| Gene Alias | B-cell differentiation factor, B-cell stimulatory factor 2, BSF2, BSF-2, CDF, CTL differentiation factor, HSF, hybridoma growth factor, IFNB2, IFN-beta-2, IL6, IL-6, Interferon beta-2, interleukin 6 (interferon, beta 2), interleukin BSF-2, interleukin-6, MGI-2A |
| Gene ID (Entrez) | 3569 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Reconstitution | Reconstitute at 100 μg/mL in PBS. |
| Species | Human |
172
R&D Systems™ Recombinant Human BMP-9 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 12.1 kDa (monomer) |
| Gene ID (Entrez) | 2658 |
| Quantity | 10 μg |
| Structural Form | Disulfide-linked homodimer |
| Source | Chinese Hamster Ovary cell line,CHO-derived human BMP-9 protein Ser320-Arg429 |
| Recombinant | Recombinant |
| Name | BMP-9 |
173
Gibco™ Human IL-15 Recombinant Protein
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Protein Family | Cytokines & Receptors |
|---|---|
| Purity or Quality Grade | ≥98% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-15 |
| Molecular Weight (g/mol) | 12.9 kDa |
| Endotoxin Level | <1 EU/ml |
| Activity | ED50 ≤ 0.5 ng/mL; determined by the dose-dependent proliferation of CTLL-2 cells. |
| Endotoxin Concentration | <1 EU/mL |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human IL-15 |
| Purification Method | Purified |
| Gene Alias | AI503618; il 15; Il15; IL-15; ILN; Interleukin; interleukin 15; Interleukin15; interleukin-15; MGC9721; M-IL-15 |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 ≤ 0.5 ng/mL; determined by the dose-dependent proliferation of CTLL-2 cells. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Cell Cycle & Proliferation, Oncology, Immunology, Signal Transduction |
| Species | Human |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
| Gene Symbol | IL15 |
| Sequence | Human IL-15 recombinant protein contains 115 amino acids |
| Storage Requirements | -20°C |
| Protein Subtype | Interleukins |
| Accession Number | P40933 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 3600 |
| Product Line | Gibco |
174
Promotions Available
R&D Systems™ Recombinant Human CD19 Fc Chimera Protein
![]()
R&D Systems™ Recombinant Human CD19 Fc Chimera Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
175
Gibco™ Human TNF-alpha Recombinant Protein
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Protein Family | Cytokines & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | TNF alpha |
| Molecular Weight (g/mol) | 17.5 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 < 0.05 ng/mL; determined by the dose-dependent cytotoxcity on L929 cells in the presence of actinomycin D. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human TNF-alpha |
| Purification Method | Purified |
| Gene Alias | APC1 protein; Cachectin; C-domain 1; C-domain 2; cTNF; DADB-70P7.1; DIF; ICD1; ICD2; Intracellular domain 1; Intracellular domain 2; N-terminal fragment; NTF; RATTNF; Tnf; TNF alpha; TNF superfamily; TNF α; TNF, macrophage-derived; TNF, monocyte-derived; TNFA; TNF-a; TNFalpha; TNF-alpha; Tnfsf1a; TNFSF2; TNFα; TNLG1F; Tumor necrosis factor; tumor necrosis factor (TNF superfamily, member 2); tumor necrosis factor alpha; tumor necrosis factor alpha (cachetin); tumor necrosis factor alpha precursor; tumor necrosis factor ligand 1F; tumor necrosis factor ligand superfamily member 2; Tumor necrosis factor, membrane form; Tumor necrosis factor, soluble form; tumor necrosis factor-alpha; tumor necrosis factor-alpha precursor; tumor-necrosis factor; tumour necrosis factor |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 < 0.05 ng/mL; determined by the dose-dependent cytotoxcity on L929 cells in the presence of actinomycin D. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Immunology, Signal Transduction, Stem Cell Research, Inflammation, Oncology |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Wet Ice |
| Content And Storage | 4°C |
| Gene Symbol | Tnf |
| Sequence | VRSSSRTPSD KPVAHVVANP QAEGQLQWLN RRANALLANG VELRDNQLVV PSEGLYLIYS QVLFKGQGCP STHVLLTHTI SRIAVSYQTK VNLLSAIKSP CQRETPEGAE AKPWYEPIYL GGVFQLEKGD RLSAEINRPD YLDFAESGQV YFGIIAL |
| Storage Requirements | 4°C |
| Protein Subtype | TNF (Tumor Necrosis Factor) |
| Accession Number | P01375 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 7124 |
| Product Line | Gibco |
176
R&D Systems™ Recombinant Human IL-4 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | >97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 15 kDa |
| Gene Symbol | IL4 |
| Endotoxin Concentration | <0.10 EU per 1 μg of the protein by the LAL method. |
| Storage Requirements | Manual defrost freezer; Avoid repeated freeze-thaw cycles; 12 mo. from receipt, -20 to -70°C as supplied; 1 mo, 2 to 8°C under sterile conditions after reconstitution; 3 mo, -20 to -70°C under sterile conditions after reconstitution |
| For Use With (Application) | Bioactivity |
| Source | <EM>E. coli</EM>-derived human IL-4 protein His25-Ser153, with an N-terminal Met |
| Accession Number | P05112 |
| Regulatory Status | RUO |
| Gene Alias | B cell growth factor 1, BCDF, B-cell stimulatory factor 1, BCGF1, BCGF-1, binetrakin, BSF1, BSF-1, IL4, IL-4B_cell stimulatory factor 1, IL4E12, interleukin 4, interleukin-4, Lymphocyte stimulatory factor 1, MGC79402, Pitrakinra |
| Gene ID (Entrez) | 3565 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
| Reconstitution | Reconstitute at 100-200 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
| Cross Reactivity | IL-4 |
| Species | Human |
177
| Regulatory Status | RUO |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 14.6 kDa |
| Formulation | protein with no preservative |
| Sequence | Human GM-CSF recombinant protein contains 128 amino acids |
| For Use With (Application) | ELISA,Immunoprecipitation,Western Blot |
| Source | E. Coli |
| Name | Human GM-CSF |
| Recombinant | Recombinant |
178
| Purity or Quality Grade | >95% by SDS-PAGE; >95% by HPLC |
|---|---|
| Conjugate | Unconjugated |
| pH Range | 7.4 |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 25.9 kDa |
| Common Name | SARS-CoV-2 Spike Protein RBD |
| Activity | 1.Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV-2 Spike RBD (Catalog: RP01258) at 2 μg/mL (100 μL/well) can bind Human ACE-2 (Catalog: RP01275) with a linear range of 0.001-2.96 ng/mL. 2.Immobilized human ACE2 on COOH Chip, can bind SARS-COV-2 Spike RBD Protein with an affinity constant of 35.3 nM as determined in a SPR assay (Nicoya OpenSPR). 3.Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV-2 Spike RBD (Catalog: RP01258) at 2 μg/mL (100 μL/well) can bind Human ACE-2 (Catalog: RP01275) with a linear range of 0.001-1.69 ng/mL. |
| Endotoxin Concentration | <1.0 EU/μg |
| Storage Requirements | -20°C or -80°C if preferred |
| Sequence | SARS-CoV-2 Spike Protein RBD, amino acids Arg319-Phe541 (Accession # YP_009724390.1) (s-RBD region) with a C-terminal His-tag |
| Expression System | HEK293 cells |
| For Use With (Application) | Control,ELISA Standard,Binding Assay,Surface Plasmon Resonance,Western Blot |
| Name | SARS-CoV-2 Spike Protein (RBD) (aa319-541), His Tag |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV2; SARS-CoV-2 |
| Product Type | Protein |
| Formulation | PBS with no preservative; pH 7.4 |
| Protein Tag | His-tag |
| Recombinant | Recombinant |
179
Gibco™ Mouse IL-4 Recombinant Protein
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Protein Family | Cytokines & Receptors |
|---|---|
| Purity or Quality Grade | >96% by SDS-PAGE and RP-HPLC |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| pH Range | 7.4 |
| Common Name | IL-4 |
| Molecular Weight (g/mol) | 13.5 kDa |
| Activity | ED50 ≤ 2 ng/mL; determined by the dose-dependent proliferation of mouse HT-2 cells. |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Mouse IL-4 |
| Purification Method | Purified |
| Gene Alias | B cell growth factor 1; B_cell stimulatory factor 1; B-cell growth factor 1; B-cell IgG differentiation factor; B-cell stimulatory factor 1; BCGF1; BCGF-1; binetrakin; BSF1; BSF-1; cytokine; H-IL-4; IGG1 induction factor; IL2; IL4; Il-4; Il4e12; ILN; Interleukin; interleukin 4; interleukin 4 variant 2; interleukin 4 variant IL-4delta2; interleukin 4 variant IL-4delta3; interleukin 4 variant IL-4int2A; interleukin 4 variant IL-4int3A; interleukin 4 variant IL-4int3B; Interleukin4; interleukin-4; interleukin-4 precursor; lymphocyte stimulatory factor 1; MGC79402; M-IL-4; Pitrakinra |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 = 2 ng/mL; determined by the dose-dependent proliferation of mouse HT-2 cells. |
| Formulation | PBS with no preservative; pH 7.4 |
| Research Category | Immunology, Stem Cell Research, Inflammation |
| Species | Mouse |
| Recombinant | Recombinant |
| Shipping Condition | Approved for shipment on Wet or Dry Ice |
| Content And Storage | -20°C |
| Gene Symbol | Il4 |
| Sequence | MHIHGCDKNH LREIIGILNE VTGEGTPCTE MDVPNVLTAT KNTTESELVC RASKVLRIFY LKHGKTPCLK KNSSVLMELQ RLFRAFRCLD SSISCTMNES KSTSLKDFLE SLKSIMQMDY S |
| Storage Requirements | -20°C |
| Protein Subtype | Interleukins |
| Accession Number | P07750 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 16189 |
| Product Line | Gibco |
180
Invitrogen™ Lectin HPA From Helix pomatia (edible snail), Alexa Fluor™ 647 Conjugate
Suitable for use in cellular imaging and flow cytometry
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More